Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01852292
Title Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | POL | ITA | IRL | HUN | GBR | FRA | ESP | DEU | CHE | CAN | AUS

Facility Status City State Zip Country Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
Dana Farber Cancer Institute IRB Boston Massachusetts 02215 United States Details
Washington U School of Medicine Center for Clinical Studies SC - BKM120H2201 Saint Louis Missouri 63110 United States Details
The Mount Sinai Hospital Dept of Oncology New York New York 10029 United States Details
University of N.C. at Chapel Hill Lineberger Comp. Cancer Ctr. Chapel Hill North Carolina 27599-7600 United States Details
University Hospitals Case Medical Center Univ. Hospitals of Cleveland Cleveland Ohio 44106 United States Details
UPMC Cancer Centers BKM120H2201 Pittsburgh Pennsylvania 15232 United States Details
Novartis Investigative Site St Leonards New South Wales 2065 Australia Details
Novartis Investigative Site Hamilton Ontario L8V 5C2 Canada Details
Novartis Investigative Site Montreal Quebec H2L 4M1 Canada Details
Novartis Investigative Site Saint Herblain cedex 44805 France Details
Novartis Investigative Site Berlin 12203 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Hannover 30625 Germany Details
Novartis Investigative Site Budapest 1082 Hungary Details
Novartis Investigative Site Budapest H-1115 Hungary Details
Novartis Investigative Site Budapest H-1122 Hungary Details
Novartis Investigative Site Nyiregyhaza 4400 Hungary Details
Novartis Investigative Site Nashik Maharashtra 422 004 India Details
Novartis Investigative Site Dehli New Delhi 110005 India Details
Novartis Investigative Site Jaipur Rajasthan 302017 India Details
Novartis Investigative Site Kolkata West Bengal 700160 India Details
Novartis Investigative Site Kerala 695 011 India Details
Novartis Investigative Site Mumbai 400 012 India Details
Novartis Investigative Site Dublin 4 Ireland Details
Novartis Investigative Site Firenze FI 50134 Italy Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Milano MI 20142 Italy Details
Novartis Investigative Site Palermo PA 90127 Italy Details
Novartis Investigative Site Roma RM 00168 Italy Details
Novartis Investigative Site Salerno SA 84131 Italy Details
Novartis Investigative Site Torino TO 10126 Italy Details
Novartis Investigative Site Venezia VE 30174 Italy Details
Novartis Investigative Site Kashiwa Chiba 277-8577 Japan Details
Novartis Investigative Site Koto-ku Tokyo 135 8550 Japan Details
Novartis Investigative Site Minato-ku Tokyo 105-8471 Japan Details
Novartis Investigative Site Seoul Korea 05505 Korea, Republic of Details
Novartis Investigative Site Seoul Seocho-gu 06591 Korea, Republic of Details
Novartis Investigative Site Warszawa 02-781 Poland Details
Novartis Investigative Site Leningrad Region Russia 188663 Russian Federation Details
Novartis Investigative Site Nizhniy Novgorod Russian Federation Details
Novartis Investigative Site St. Petersburg 197758 Russian Federation Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Basel 4031 Switzerland Details
Novartis Investigative Site Genève 1211 Switzerland Details
Novartis Investigative Site Tainan Taiwan ROC 70421 Taiwan Details
Novartis Investigative Site Kaohsiung City 83301 Taiwan Details
Novartis Investigative Site Taichung City 407 Taiwan Details
Novartis Investigative Site Songkla Hat Yai 90110 Thailand Details
Novartis Investigative Site Bangkok 10330 Thailand Details
Novartis Investigative Site Bangkok 10700 Thailand Details
Novartis Investigative Site Glasgow Scotland G12 0YN United Kingdom Details
Novartis Investigative Site London NW1 2PJ United Kingdom Details
Novartis Investigative Site London SE1 9RT United Kingdom Details
Novartis Investigative Site Manchester M20 9BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field